HYLORIS PHARMACEUTICALS
Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. Hyloris Pharmaceuticals develop innovative proprietary products that offer significant advantages compared to currently available alternatives.
HYLORIS PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2013-01-01
Status:
Active
Contact:
+32 (0)4 346 02 07
Total Funding:
30 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Meusinvest (Noshaq)
Meusinvest (Noshaq) investment in Venture Round - Hyloris Pharmaceuticals
Saffelberg Investments
Saffelberg Investments investment in Venture Round - Hyloris Pharmaceuticals
Scorpiaux
Scorpiaux investment in Venture Round - Hyloris Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-06 | Pleco Therapeutics | Hyloris Pharmaceuticals investment in Series A - Pleco Therapeutics | 17.3 M EUR |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-05-26 | Hyloris appoints Patrick Jeanmart as Chief Financial Officer |
More informations about "Hyloris Pharmaceuticals"
Hyloris Pharmaceuticals - Crunchbase Investor Profile …
Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. Hyloris Pharmaceuticals develop innovative proprietary …See details»
Hyloris Pharmaceuticals: Contact Details and Business Profile
Hyloris Pharmaceuticals is based in Liège, Walloon Region. What is the NAICS code for Hyloris Pharmaceuticals? The NAICS codes for Hyloris Pharmaceuticals are [32, 325, 32541, 3254] .See details»
Hyloris Pharmaceuticals Company Description - Stock Analysis
Dec 13, 2024 Hyloris Pharmaceuticals SA engages in the research, development, and manufacture of pharmaceutical products to address unmet medical needs. The company …See details»
Hyloris Pharmaceuticals - PitchBook
Hyloris Pharmaceuticals SA is an early-stage specialty pharmaceutical company focused on adding value to the healthcare system by reformulating pharmaceuticals. The company …See details»
Hyloris Pharmaceuticals - LinkedIn
Hyloris Pharmaceuticals | 7,908 followers on LinkedIn. We are committed to addressing unmet medical needs through reinventing existing medications | We are a specialty biopharma …See details»
Corporate Presentation - Hyloris
This presentation has been prepared by, and is the sole responsibility of, Hyloris Pharmaceuticals SA (the "Company") for discussions with investors in relation to the Company and its group. …See details»
Hyloris Pharmaceuticals SA | HYL - Financial Reports
Jun 13, 2023 Access Hyloris Pharmaceuticals SA's (HYL) complete financial documents, including 2023 annual reports, quarterly statements, and ESG reports. Get real-time updates …See details»
Hyloris Pharmaceuticals in Belgium - ICH GCP
About Hyloris Pharmaceuticals. We are a specialty biopharma company focused on innovating, reinventing, and optimising existing medications to address important healthcare needs and …See details»
Hyloris Pharmaceuticals - Craft
Hyloris Pharmaceuticals is a company that develops specialty pharmaceuticals intended to add value to patients and the healthcare system. The company specializes in reformulating well …See details»
Our Governance - Hyloris
Prior to her role at 4P, Revital was the Head of PharmaSeed Europe (2013-2014) a research organization specialized in early development where she supervised all BD activities, finance …See details»
Hyloris Pharmaceuticals - VentureRadar
" Hyloris is a specialty biopharma company focused on innovating, reinventing, and optimising existing medications to address important healthcare needs and deliver relevant …See details»
Hyloris Pharmaceuticals - Products, Competitors, Financials, …
Hyloris Pharmaceuticals primarily sells to sectors that require advanced treatment options for conditions such as post-operative pain and atrial fibrillation. It was founded in 2013 and is …See details»
Hyloris Pharmaceuticals - Funding, Financials, Valuation & Investors
Hyloris Pharmaceuticals is registered under the ticker EBR:HYL . Their stock opened with €10.75 in its Jun 29, 2020 IPO. Hyloris Pharmaceuticals is funded by 4 investors. Walloon and …See details»
Hyloris Pharmaceuticals Reports Preliminary 2024 Half-Year …
Pharmaceutical o., Ltd., a pharmaceutical company specializing in injectable medications, was signed in September 2024. • Regulatory approvals for Maxigesic® IV were received in several …See details»
Hyloris Pharmaceuticals - Contacts, Employees, Board Members, …
Hyloris Pharmaceuticals has 2 current employee profiles, including Chief Business Development Officer , Board Member Thomas Jacobsen. Hyloris Pharmaceuticals has 1 board member or …See details»
Company Hyloris Pharmaceuticals SA - MarketScreener.com
Dec 31, 2011 Hyloris Pharmaceuticals SA is a specialty biopharma company identifying and unlocking hidden potential in existing medications for the benefit of patients and the healthcare …See details»
Hyloris releases Annual Report 2022, including ESG objectives
Hyloris is based in Liège, Belgium. For more information, visit www.hyloris.com and follow-us on LinkedIn. For more information, contact Hyloris Pharmaceuticals: Stijn Van Rompay, CEO …See details»
Hyloris Pharmaceuticals : Investor Meetings - Geneva
Oct 4, 2023 Hyloris Pharmaceuticals SA is a specialty biopharma company identifying and unlocking hidden potential in existing medications for the benefit of patients and the healthcare …See details»
Here's Why We're Not Too Worried About Hyloris …
1 day ago Hyloris Pharmaceuticals' cash burn of €13m is about 8.5% of its €148m market capitalisation. Given that is a rather small percentage, it would probably be really easy for the …See details»